Fuller & Thaler Asset Management’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.4M | Buy |
5,001
+600
| +14% | +$158K | ﹤0.01% | 388 |
|
|
2026
Q1 | $1.17M | Buy |
4,401
+290
| +7% | +$78.5K | ﹤0.01% | 383 |
|
|
2025
Q4 | $1.03M | Sell |
4,111
-32,029
| -89% | -$8.51M | ﹤0.01% | 392 |
|
|
2025
Q3 | $10.4M | Sell |
36,140
-4,793
| -12% | -$1.28M | 0.04% | 289 |
|
|
2025
Q2 | $10.7M | Buy |
40,933
+1,362
| +3% | +$332K | 0.04% | 289 |
|
|
2025
Q1 | $9.21M | Buy |
39,571
+1,181
| +3% | +$287K | 0.04% | 297 |
|
|
2024
Q4 | $8.8M | Buy |
38,390
+1,555
| +4% | +$357K | 0.03% | 312 |
|
|
2024
Q3 | $8.23M | Sell |
36,835
-3,450
| -9% | -$758K | 0.03% | 304 |
|
|
2024
Q2 | $8.2M | Buy |
40,285
+1,762
| +5% | +$358K | 0.04% | 299 |
|
|
2024
Q1 | $8.42M | Buy |
38,523
+4,169
| +12% | +$918K | 0.04% | 284 |
|
|
2023
Q4 | $7.81M | Sell |
34,354
-6,630
| -16% | -$1.39M | 0.04% | 276 |
|
|
2023
Q3 | $8.24M | Sell |
40,984
-3,163
| -7% | -$667K | 0.05% | 267 |
|
|
2023
Q2 | $9.15M | Buy |
44,147
+384
| +0.9% | +$74.5K | 0.05% | 255 |
|
|
2023
Q1 | $8.63M | Buy |
43,763
+4,864
| +13% | +$1M | 0.05% | 253 |
|
|
2022
Q4 | $7.87M | Buy |
38,899
+4,582
| +13% | +$896K | 0.05% | 241 |
|
|
2022
Q3 | $6.04M | Buy |
34,317
+4,874
| +17% | +$998K | 0.04% | 258 |
|
|
2022
Q2 | $5.93M | Buy |
29,443
+14,346
| +95% | +$3.06M | 0.04% | 271 |
|
|
2022
Q1 | $3.42M | Buy |
15,097
+1,862
| +14% | +$438K | 0.02% | 305 |
|
|
2021
Q4 | $3.57M | Buy |
13,235
+815
| +7% | +$202K | 0.02% | 296 |
|
|
2021
Q3 | $3M | Buy |
12,420
+3,027
| +32% | +$763K | 0.02% | 305 |
|
|
2021
Q2 | $2.23M | Buy |
9,393
+3,887
| +71% | +$886K | 0.01% | 346 |
|
|
2021
Q1 | $1.21M | Buy |
5,506
+1,863
| +51% | +$374K | 0.01% | 361 |
|
|
2020
Q4 | $637K | Sell |
3,643
-59
| -2% | -$10.2K | 0.01% | 377 |
|
|
2020
Q3 | $599K | Buy |
3,702
+2,131
| +136% | +$338K | 0.01% | 370 |
|
|
2020
Q2 | $224K | Sell |
1,571
-175
| -10% | -$24.2K | ﹤0.01% | 389 |
|
|
2020
Q1 | $190K | Hold |
1,746
| – | – | ﹤0.01% | 389 |
|
|
2019
Q4 | $254K | Buy |
1,746
+175
| +11% | +$25.3K | ﹤0.01% | 375 |
|
|
2019
Q3 | $227K | Hold |
1,571
| – | – | ﹤0.01% | 376 |
|
|
2019
Q2 | $233K | Hold |
1,571
| – | – | ﹤0.01% | 372 |
|
|
2019
Q1 | $207K | Hold |
1,571
| – | – | ﹤0.01% | 362 |
|
|
2018
Q4 | $171K | Hold |
1,571
| – | – | ﹤0.01% | 367 |
|
|
2018
Q3 | $234K | Buy |
1,571
+814
| +108% | +$124K | ﹤0.01% | 349 |
|
|
2018
Q2 | $117K | Buy |
757
+291
| +62% | +$43.9K | ﹤0.01% | 485 |
|
|
2018
Q1 | $65K | Hold |
466
| – | – | ﹤0.01% | 650 |
|
|
2017
Q4 | $64K | Buy |
+466
| New | +$61.6K | ﹤0.01% | 586 |
|
Other funds holding LH
Fuller & Thaler Asset Management's LH Position: Q2 2026 in Review
Fuller & Thaler Asset Management increased its Labcorp (LH) stake by 14% in Q2 2026, buying an estimated $158K and bringing the position to 5,001 shares worth $1.4M. The position accounts for ﹤0.01% of the portfolio, ranked #388.
Fuller & Thaler Asset Management first reported a position in LH in Q4 2017 and has held it in 35 quarters since. The position peaked at $10.7M in Q2 2025. 1,053 funds tracked by Wall St. Rank hold LH as of Q2 2026.
- Fuller & Thaler Asset Management held 5,001 shares of Labcorp worth $1.4M as of Q2 2026.
- Fuller & Thaler Asset Management bought 600 Labcorp shares in Q2 2026, an estimated $158K.
- Labcorp made up ﹤0.01% of Fuller & Thaler Asset Management's portfolio in Q2 2026, its #388 holding.
- Fuller & Thaler Asset Management first reported a position in Labcorp in Q4 2017 and has held it in 35 quarters since.
- Fuller & Thaler Asset Management's Labcorp position peaked at $10.7M in Q2 2025.
- 1,053 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.
Based on Fuller & Thaler Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.